Pages that link to "Q35019424"

The following pages link to A safer vaccine for Alzheimer's disease? (Q35019424):

Displaying 22 items.

• The immunotherapy of Alzheimer's disease (Q24804900) (← links)
• Systemic catabolism of Alzheimer's Abeta40 and Abeta42. (Q31107099) (← links)
• Amyloid-beta immunotherapy for Alzheimer's disease (Q33954737) (← links)
• Catalytic immunoglobulin gene delivery in a mouse model of Alzheimer's disease: prophylactic and therapeutic applications (Q34345602) (← links)
• Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP PS1 mice (Q34506405) (← links)
• Oral administration of a fusion protein between the cholera toxin B subunit and the 42-amino acid isoform of amyloid-β peptide produced in silkworm pupae protects against Alzheimer's disease in mice (Q34624985) (← links)
• Treatment of Alzheimer's disease: current status and new perspectives. (Q35206995) (← links)
• Yin and Yang: complement activation and regulation in Alzheimer’s disease (Q35563953) (← links)
• Muscle-directed anti-Aβ single-chain antibody delivery via AAV1 reduces cerebral Aβ load in an Alzheimer's disease mouse model (Q36532822) (← links)
• An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome (Q36739111) (← links)
• Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease (Q36761690) (← links)
• Therapeutic approaches for prion and Alzheimer's diseases (Q36872884) (← links)
• Amyloid-beta immunisation for Alzheimer's disease (Q37230661) (← links)
• What does complement do in Alzheimer's disease? Old molecules with new insights (Q37368120) (← links)
• Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy (Q37685285) (← links)
• Therapeutic strategies against protein misfolding in neurodegenerative diseases (Q38088318) (← links)
• Efficacy of a Therapeutic Vaccine Using Mutated β-amyloid Sensitized Dendritic Cells in Alzheimer’s Mice (Q39605286) (← links)
• MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice (Q41983452) (← links)
• CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation (Q42554166) (← links)
• Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease (Q46496723) (← links)
• Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease (Q48300537) (← links)
• Mass spectrometric approaches for elucidation of antigenantibody recognition structures in molecular immunology (Q50145291) (← links)